AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rabliss 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Astrapia Remedies Private Limited

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Rabliss 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD, or acid reflux) is treated with the combination medication, Rabliss 30mg/20mg sustained-release capsules. This medication alleviates symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Rabliss 30mg/20mg SR capsules should be taken on an empty stomach, following your doctor's prescribed dosage and duration. Your individual dose depends on your response and condition; continue treatment as directed to prevent symptom recurrence and potential worsening. Inform your healthcare provider of all other medications you're using, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until you assess the drug's impact. Limit alcohol consumption due to potential drowsiness exacerbation. Lifestyle changes, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to starting Rabliss, disclose any kidney or liver conditions, and inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

Uses of Rabliss 30mg/20mg Capsule SR

Managing acid reflux and peptic ulcers.

Major Benefits of Rabliss 30mg/20mg Capsule SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire capsule without chewing, crushing, or breaking it. Consume Rabliss 30mg/20mg SR Capsules on an empty stomach.

Common Side effects of Rabliss 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Rabliss 30mg/20mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 30mg/20mg Rabliss SR capsule should be swallowed whole; do not break, crush, or chew it. Administer this medication on an empty stomach.

How Rabliss 30mg/20mg Capsule SR works:

Rabliss SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with the proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating efficient food passage through the stomach. Rabeprazole decreases gastric acid production, providing relief from heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when combining alcohol and Rabliss 30mg/20mg sustained-release capsules. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Rabliss 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Rabliss 30mg/20mg SR capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Rabliss 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving is inadvisable if such effects are experienced.

KidneyKidneyCAUTION

Exercise caution when administering Rabliss 30mg/20mg sustained-release capsules to individuals with impaired renal function. Dosage modification of Rabliss 30mg/20mg sustained-release capsules may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Rabliss 30mg/20mg SR capsules; dosage modification may be necessary. Consult your physician. Rabliss 30mg/20mg SR capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Rabliss 30mg/20mg Capsule SR :

Should you forget to take a Rabliss 30mg/20mg sustained-release capsule, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Rabliss 30mg/20mg Capsule SR

LabelValue
Potential for Dependence None.
Medication Classification Gastrointestinal tract

FAQs on Rabliss 30mg/20mg Capsule SR

Each Rabliss 30mg/20mg sustained-release capsule contains Domperidone and Rabeprazole. This dual-action formulation addresses symptoms of acidity, heartburn, and gastroesophageal reflux disease (GERD), a disorder characterized by stomach acid reflux into the esophagus. It's also indicated for gastric and duodenal ulcers. Domperidone's mechanism involves enhancing gut motility, facilitating efficient gastric emptying and thereby mitigating vomiting.
Patients with hypersensitivity to rabeprazole, domperidone, or any inactive components of Rabliss 30mg/20mg Capsule SR should avoid this medication. Individuals with pre-existing liver or kidney conditions require careful monitoring when using this drug.
Indeed, taking Rabliss 30mg/20mg sustained-release capsules may lead to xerostomia (dry mouth). This side effect is attributed to the Domperidone component. To alleviate dry mouth, increase your fluid intake. Keep water readily available, especially overnight. Reduce alcohol consumption and abstain from smoking. If experiencing dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Indeed, diarrhea is a potential side effect of Rabliss 30mg/20mg sustained-release capsules. Should diarrhea occur, increased fluid intake is recommended. Dietary adjustments, such as limiting greasy or deep-fried foods, may be beneficial. Consult your physician if diarrhea continues or if symptoms of dehydration, such as reduced urination and dark, concentrated urine, appear.
Store this medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label or packaging insert. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Rabliss 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse reactions such as abdominal discomfort, diarrhea, flatulence, dry mouth, vertigo, or headache. Less frequent or rare side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Rabliss 30mg/20mg sustained-release capsules is before the initial daily meal or while fasting.
Taking Rabliss 30mg/20mg sustained-release capsules may elevate the likelihood of experiencing an abnormal heart rhythm (severe arrhythmias). While a serious potential adverse effect, the probability of this occurring is minimal. Individuals over 60 might face a marginally increased risk.
Each Rabliss 30mg/20mg sustained-release capsule contains Domperidone and Rabeprazole, working together to manage heartburn, acid reflux (GERD), and ulcers affecting the stomach and duodenum. GERD is characterized by stomach acid rising into the esophagus. Domperidone's role is to alleviate vomiting by stimulating improved gastrointestinal motility, facilitating smoother food passage through the stomach.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipient within Rabliss 30mg/20mg Capsule SR should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, taking Rabliss 30mg/20mg SR capsules can lead to xerostomia (dry mouth), a side effect attributed to the Domperidone component. Should you experience this, increase your water consumption. Keeping water readily available overnight is advisable. Reducing alcohol consumption and abstaining from smoking are also recommended. For dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a possible side effect of Rabliss 30mg/20mg SR Capsules. If diarrhea occurs, increase fluid intake. Restrict consumption of high-fat foods while taking this medication. Consult your physician if diarrhea continues or if you exhibit symptoms of dehydration, such as reduced urination and dark, concentrated urine.
Rabliss 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience side effects such as diarrhea, abdominal pain, gas, dry mouth, vertigo, or headache. Less frequent or rare adverse reactions are also possible. Report any ongoing issue to your physician during treatment.
Optimal administration of Rabliss 30mg/20mg sustained-release capsules is before breakfast or on an empty stomach.
Taking Rabliss 30mg/20mg sustained-release capsules may raise the likelihood of experiencing an irregular heartbeat, a potentially severe arrhythmia. While this is a serious adverse event, the probability of occurrence remains quite small. However, the risk might be marginally elevated for individuals over sixty.
Retain this medication in its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Prevent access by children, animals, and others.
Rabliss 30mg/20mg Capsule...
101
MRP 123
17% off